– Bloomberg
Magenta Therapeutics Q3 EPS $(0.27) Up From $(0.30) YoY
Magenta Therapeutics (NASDAQ:MGTA) reported quarterly losses of $(0.27) per share. This is a 10 percent increase over losses of $(0.30) per share from the same period last year.
